Biomark Diagnostics Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Millions EUR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 29, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	29	14	17	10	11	21
Market Cap Growth	190.12%	-15.29%	61.96%	-7.18%	-45.46%	140.92%
Enterprise Value	29	15	18	12	12	21
Last Close Price	0.28	0.14	0.19	0.13	0.14	0.27
PS Ratio	384.07	145.04	152.12	100.50	356.91	-
PB Ratio	54.90	12.85	-40.73	-13.42	-24.67	-386.98
P/TBV Ratio	54.90	12.85	-	-	-	-
EV/Sales Ratio	-	154.52	161.35	110.73	393.16	-
Debt / Equity Ratio	0.93	0.64	-2.54	-1.44	-3.09	-12.70
Asset Turnover	0.09	0.07	0.18	0.14	0.04	-
Quick Ratio	1.73	2.14	0.16	0.06	0.31	0.98
Current Ratio	1.73	2.14	0.16	0.08	0.33	1.00
Return on Equity (ROE)	-	-340.70%	-	-	-	-
Return on Assets (ROA)	-79.14%	-60.59%	-117.29%	-104.38%	-66.20%	-80.77%
Return on Capital Employed (ROCE)	-197.50%	-107.60%	1099.30%	197.40%	4328.70%	-3366.60%
Earnings Yield	-3.49%	-8.62%	-5.75%	-11.94%	-9.27%	-3.57%
FCF Yield	-3.00%	-4.90%	-3.98%	-5.96%	-8.06%	-2.64%
Buyback Yield / Dilution	-10.10%	-6.67%	-2.97%	-6.22%	-6.31%	-2.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.